HSBC HOLDINGS PLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 195 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,005,538
+43.4%
78,404
+35.0%
0.00%
+50.0%
Q2 2023$2,095,363
-45.4%
58,058
-42.3%
0.00%
-60.0%
Q1 2023$3,837,705
-19.8%
100,564
+19.5%
0.01%
-16.7%
Q4 2022$4,786,997
+46.0%
84,122
+1.5%
0.01%
+20.0%
Q3 2022$3,279,000
+46.8%
82,904
+63.2%
0.01%
+66.7%
Q2 2022$2,234,000
-3.2%
50,786
-12.2%
0.00%0.0%
Q1 2022$2,308,000
-9.0%
57,838
-8.0%
0.00%
+50.0%
Q4 2021$2,536,000
+34.0%
62,840
+35.1%
0.00%0.0%
Q3 2021$1,892,000
+280.7%
46,524
+148.4%
0.00%
+100.0%
Q3 2020$497,000
+170.1%
18,732
+80.8%
0.00%
Q1 2020$184,000
-21.4%
10,362
-20.9%
0.00%
Q4 2019$234,000
-59.6%
13,107
-64.9%
0.00%
-100.0%
Q3 2019$579,000
+116.9%
37,342
+125.0%
0.00%
Q1 2019$267,000
+70.1%
16,597
+54.6%
0.00%
Q4 2018$157,000
-15.6%
10,738
-42.8%
0.00%
Q4 2016$186,000
+64.6%
18,782
+47.5%
0.00%
-100.0%
Q2 2012$113,00012,7320.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders